Research output per year
Research output per year
Personal profile
Fields of Science
- 3111 Biomedicine
- Neurodegeneration
- 317 Pharmacy
- Pharmacology and toxicology
- 1184 Genetics, developmental biology, physiology
- Neurophysiology
International and National Collaboration
Publications and projects within past five years.
-
Combining fibril-induced alpha-synuclein aggregation and 6-hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration
Singh, A., Panhelainen, A., Reunanen, S., Luk, K. C. & Voutilainen, M., Jan 2024, In: European Journal of Neuroscience. 59, 1, p. 132-153 22 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration
Singh, A., Panhelainen, A. & Voutilainen, M. H., 1 Nov 2023, In: Neuroscience Letters. 816, 6 p., 137510.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
Mätlik, K., Garton, D. R., Montano-Rodriguez, A. R., Olfat, S., Eren, F., Casserly, L., Damdimopoulos, A., Panhelainen, A., Porokuokka, L. L., Kopra, J. J., Turconi, G., Schweizer, N., Bereczki, E., Piehl, F., Engberg, G., Cervenka, S., Piepponen, T. P., Zhang, F-P., Sipila, P., Jakobsson, J., & 3 others, Aug 2022, In: Molecular Psychiatry. 27, p. 3247-3261 15 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access -
Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
Albert, K., Raymundo, D. P., Panhelainen, A., Eesmaa, A., Shvachiy, L., Araujo, G. R., Chmielarz, P., Yan, X., Singh, A., Cordeiro, Y., Palhano, F. L., Foguel, D., Luk, K. C., Domanskyi, A., Voutilainen, M. H., Huttunen, H. J., Outeiro, T. F., Saarma, M., Almeida, M. S. & Airavaara, M., 1 Sept 2021, In: Molecular therapy. 29, 9, p. 2821-2840 20 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
Nissen, S. K., Ferreira, S. A., Nielsen, M. C., Schulte, C., Shrivastava, K., Hennig, D., Etzerodt, A., Graversen, J. H., Berg, D., Maetzler, W., Panhelainen, A., Moller, H. J., Brockmann, K. & Romero-Ramos, M., Apr 2021, In: Movement Disorders. 36, 4, p. 963-976 14 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Novel therapeutics for neurodegeneration
Anne Panhelainen (Supervisor)
2018 → …Activity: Examination types › Supervisor or co-supervisor of doctoral thesis
-
Columbia University, professor David Sulzer's group
Anne Panhelainen (Visiting researcher)
1 Aug 2013 → 31 Jul 2014Activity: Visiting an external institution types › Academic visit to other institution
Press/Media
-
Neurotrophic factor GDNF is an important regulator of dopamine neurons in the brain
Jaan-Olle Andressoo, Jaakko Kopra & Anne Panhelainen
15/02/2017 → 16/02/2017
4 items of Media coverage
Press/Media: Press / Media